BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 8246154)

  • 1. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    Zalups RK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive losses of renal mass and the renal and hepatic disposition of administered inorganic mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):121-31. PubMed ID: 7839359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductions in renal mass and the nephropathy induced by mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):366-79. PubMed ID: 9144453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
    Juresa D; Blanusa M; Kostial K
    Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DMPS as a rescue agent for the nephropathy induced by mercuric chloride.
    Zalups RK; Gelein RM; Cernichiari E
    J Pharmacol Exp Ther; 1991 Jan; 256(1):1-10. PubMed ID: 1671092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced renal outer medullary uptake of mercury associated with uninephrectomy: implication of a luminal mechanism.
    Zalups RK
    J Toxicol Environ Health; 1997 Feb; 50(2):173-94. PubMed ID: 9048960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance proteins and the renal elimination of inorganic mercury mediated by 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid.
    Bridges CC; Joshee L; Zalups RK
    J Pharmacol Exp Ther; 2008 Jan; 324(1):383-90. PubMed ID: 17940195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of mercury burdens in rats by chelation with dimercaptopropane sulfonate.
    Cherian MG; Miles EF; Clarkson TW; Cox C
    J Pharmacol Exp Ther; 1988 May; 245(2):479-84. PubMed ID: 3367303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversion or prevention of biliary outflow from the liver diminishes the renal uptake of injected inorganic mercury.
    Zalups RK; Barfuss DW
    Drug Metab Dispos; 1996 Apr; 24(4):480-6. PubMed ID: 8801064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of different degrees of reduced renal mass on the renal and hepatic disposition of administered cadmium.
    Zalups RK
    J Toxicol Environ Health; 1997 Jun; 51(3):245-64. PubMed ID: 9183381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased inorganic mercury in spinal motor neurons following chelating agents.
    Ewan KB; Pamphlett R
    Neurotoxicology; 1996; 17(2):343-9. PubMed ID: 8856730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basolateral uptake of mercuric conjugates of N-acetylcysteine and cysteine in the kidney involves the organic anion transport system.
    Zalups RK
    J Toxicol Environ Health A; 1998 Sep; 55(1):13-29. PubMed ID: 9747601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRP2 and the DMPS- and DMSA-mediated elimination of mercury in TR(-) and control rats exposed to thiol S-conjugates of inorganic mercury.
    Bridges CC; Joshee L; Zalups RK
    Toxicol Sci; 2008 Sep; 105(1):211-20. PubMed ID: 18511429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effectiveness of 2,3-dimercaptopropanol (BAL) and meso-2,3-dimercaptosuccinic acid (DMSA) as protective agents against mercuric chloride-induced nephrotoxicity in rats.
    de la Torre A; Bellés M; Llobet JM; Mayayo E; Domingo JL
    Biol Trace Elem Res; 1998 Jul; 63(1):1-10. PubMed ID: 9764565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of glutathione in the kidney and the renal disposition of administered inorganic mercury.
    Zalups RK; Lash LH
    Drug Metab Dispos; 1997 Apr; 25(4):516-23. PubMed ID: 9107552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study on the effects of BSO, GSH, vitamin C and DMPS on the nephrotoxicity induced by mercury].
    Zhao-Fa X; Jing-Hua Y; Jia-Ming Y; Zhong-Wei Y
    Wei Sheng Yan Jiu; 2005 Sep; 34(5):533-6. PubMed ID: 16329589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of 2,3-dimercaptopropane-1-sulfonate and dimercaptosuccinic acid on the mobilization of mercury from tissues of rats pretreated with mercuric chloride, phenylmercury acetate or mercury vapors.
    Buchet JP; Lauwerys RR
    Toxicology; 1989 Mar; 54(3):323-33. PubMed ID: 2539660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of uninephrectomy and mercuric chloride on renal glutathione homeostasis.
    Zalups RK; Lash LH
    J Pharmacol Exp Ther; 1990 Sep; 254(3):962-70. PubMed ID: 2395124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luminal and basolateral mechanisms involved in the renal tubular uptake of inorganic mercury.
    Zalups RK; Minor KH
    J Toxicol Environ Health; 1995 Sep; 46(1):73-100. PubMed ID: 7666495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexing activity of 2,3-dimercapto-1-propanesulfonate and its disulfide auto-oxidation product in rat kidney.
    Diamond GL; Klotzbach JM; Stewart JR
    J Pharmacol Exp Ther; 1988 Jul; 246(1):270-4. PubMed ID: 3392658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.